Dendritic cells expand Epstein Barr virus specific CD8+ T cell responses more efficiently than EBV transformed B cells

Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin’s lymphoma

B cell tumor vaccine enhanced by covalent attachment of immunoglobulin to surface proteins on dendritic cells

B-cell lymphoma and myeloma protection induced by idiotype vaccination with dendritic cells is mediated entirely by T cells in mice

Immunotherapy in multiple myeloma–possibility or probability?

Adjuvant IL-15 does not enhance the efficacy of tumor cell lysate-pulsed dendritic cell vaccines for active immunotherapy of T cell lymphoma

Immunoselection of functional CMRF-56+ blood dendritic cells from multiple myeloma patients for immunotherapy

Therapeutic vaccination against murine lymphoma by intratumoral injection of naive dendritic cells

Vaccine therapy for non-Hodgkin’s lymphoma and other B-cell malignancies

Toward personalized immunotherapy for non-Hodgkin lymphoma: targeting the idiotypic immunoglobulin